Workflow
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RARE
TMX Newsfile· 2026-02-14 03:21
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/. New York, New York--(Newsfile Corp. - February 13, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) between August 3, 2023 and December 26, 2025, inclusive (the "Class Period"). A class ac ...
Antero Midstream: Potential For $1.3 Billion In 2027 Adjusted EBITDA (Rating Downgrade)
Seeking Alpha· 2026-02-14 03:13
Group 1 - Antero Midstream (AM) ended 2025 with adjusted EBITDA and free cash flow after dividends at the high end of its revised guidance, showing improvement over its original guidance [1] - The company is part of the Distressed Value Investing community, which focuses on value opportunities and distressed plays, particularly in the energy sector [1] Group 2 - The article is authored by Aaron Chow, who has over 15 years of analytical experience and is a top-rated analyst on TipRanks [1] - Aaron Chow previously co-founded a mobile gaming company that was acquired by PENN Entertainment, utilizing his analytical skills in economic modeling for mobile apps [1]
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Prnewswire· 2026-02-14 03:11
Core Viewpoint - The article discusses a securities fraud class action lawsuit against uniQure N.V. due to a significant delay in FDA approval for its drug candidate AMT-130, which led to a 49% decline in the company's stock price [1]. Summary by Relevant Sections Lawsuit Details - Investors who purchased shares of uniQure between September 24, 2025, and October 31, 2025, have until April 13, 2026, to file lead plaintiff applications in the class action lawsuit [1]. - The lawsuit alleges that uniQure and its executives failed to disclose material information, violating federal securities laws [1]. FDA Approval and Stock Impact - During the class period, uniQure indicated a high likelihood of receiving accelerated FDA approval for AMT-130 following a planned Biologics License Application (BLA) submission in Q1 2026 [1]. - On November 3, 2025, uniQure announced that the FDA no longer agreed that the data from Phase I/II studies were adequate for BLA submission, resulting in a stock price drop of $33.40, or over 49%, from $67.69 to $34.29 per share [1].
INVESTOR ALERT: Ultragenyx Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
Businesswire· 2026-02-14 03:10
SAN DIEGO--(BUSINESS WIRE)---- $RARE #RARE--Ultragenyx allegedly misled investors about setrusumab's potential Phase 3 study success in reducing fracture rates. ...
Airbnb plans to bake in AI features for search, discovery and support
TechCrunch· 2026-02-14 02:40
Core Insights - Airbnb is planning to integrate AI features powered by large language models to enhance user experience in searching for listings, trip planning, and property management for hosts [1][2] - The company aims to create an AI-native experience that personalizes interactions and improves operational efficiency [2] AI Features and Development - Airbnb is currently testing a new feature that allows users to search and inquire about properties using natural language queries [2] - The existing AI-powered customer service bot handles one-third of customer issues without human intervention, with plans to expand its capabilities to voice support and multiple languages [7][8] - The company is experimenting with making AI search more conversational and is considering the introduction of sponsored listings in the future [3][4] Leadership and Strategy - Airbnb's new CTO, Ahmad Al-Dahle, will leverage AI expertise to utilize identity and review data for enhancing app functionality [6] - The company has set a goal for 100% of its engineers to use AI tools, currently at 80% [8] Financial Performance - Airbnb reported fourth-quarter revenue of $2.78 billion, reflecting a 12% increase year-over-year [9]
FCT: No Near-Term Growth Catalyst
Seeking Alpha· 2026-02-14 02:32
Core Insights - The article emphasizes the importance of a hybrid investment strategy that combines classic dividend growth stocks with Business Development Companies, REITs, and Closed End Funds to enhance investment income while achieving total returns comparable to traditional index funds [1]. Investment Strategy - The company advocates for a diversified approach to investing, suggesting that a solid base of dividend growth stocks can be effectively supplemented with other asset types to maximize income potential [1]. - The strategy aims to achieve a total return that aligns with the performance of the S&P index, indicating a balanced focus on both growth and income [1].
Carrier Connect Data Solutions Files Business Acquisition Report
Thenewswire· 2026-02-14 02:30
Core Insights - Carrier Connect Data Solutions Inc. has filed a Business Acquisition Report regarding its acquisition of PureColo Inc. [1] Company Overview - Carrier Connect Data Solutions Inc. focuses on rolling up Tier II/III data centers internationally, specializing in co-location and data center solutions for AI companies, service providers, enterprises, and small businesses [3] - The company operates as a carrier-neutral organization, meaning its systems are fully independent and owned outright within its leased space [3] - The primary markets for the company include Vancouver and Ottawa in Canada, and Perth in Australia, serving clients who utilize its facilities as either their primary data center or as an ancillary site [3]
Upstart: A Directional Bet On Falling Rates
Seeking Alpha· 2026-02-14 02:16
Core Insights - The article discusses the investment positions held by analysts in specific companies, indicating a bullish sentiment towards UPST, SOFI, and AFRM [1] Group 1 - Analysts have disclosed beneficial long positions in UPST, SOFI, and AFRM, suggesting confidence in these stocks [1] - The article emphasizes that the opinions expressed are personal and not influenced by external compensation [1]
Deveron Completes Transaction to Sell Its Assets
TMX Newsfile· 2026-02-14 02:14
Core Viewpoint - Deveron Corp. has sold substantially all of its assets in a transaction with RRL Ultimate Parent, LLC and other purchasers, as part of a share and asset purchase agreement [1]. Company Overview - Deveron is an agriculture technology company focused on using data and insights to enhance agricultural productivity, reduce costs, and improve farm outcomes. The company employs a digital process that leverages data collected from farms across North America to provide unbiased production decision interpretations and optimize input use [4]. Transaction Details - The transaction involves a share and asset purchase agreement with multiple parties, including RRL Ultimate Parent, LLC and Maple NewCo, LLC, along with various asset vendors [1]. - Following the completion of the transaction, the company may be subject to migration to the NEX Board of the TSXV unless it can demonstrate compliance with the Continued Listing Requirements [2].
U.S. Debt Crisis Deepens as Military Prepares for Sustained Campaign Against Iran
Stock Market News· 2026-02-14 02:08
Key Takeaways Geopolitical Tensions Escalate in the Middle East The United States military is actively preparing for a prolonged, sustained military campaign against Iran that could last several weeks. According to senior officials, this planning represents a significant escalation from previous "one-off" strikes, with potential targets including Iranian state and security facilities. The Pentagon is deploying the USS Gerald R. Ford to the Middle East to join existing assets like the USS Abraham Lincoln. Th ...